Skip Navigation
Skip to contents
Search
Home
Current
Current issue
Ahead-of print
Browse
All issues
Article by category
Article by topic
Article by Category
2023-2024
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
Collections
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
For contributors
For Authors
Instructions for authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
About
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
Editorial policy
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
E-Submission
KDA
Contact us
E-SUBMISSION
mobile menu button
Current
Current issue
Ahead-of print
Browse
All issues
Article by category
Article by topic
Article by Category
2023-2024
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
Collections
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
For contributors
For Authors
Instructions for authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
About
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
Editorial policy
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
Articles
Page Path
HOME
>
Diabetes Metab J
>
Volume 28(2); 2004
> Article
Editorial
Significance of Anti-GAD Antibodies in Lean Patients with Type 2 Diabetes Mellitus.
Yong Soo Park
Diabetes & Metabolism Journal 2004;28(2):63-65
DOI:
https://doi.org/
Published online: April 1, 2004
901
Views
18
Download
0
Crossref
0
Scopus
Author Affiliations
Article notes
Hanyang University, College of Medicine, Seoul, Korea.
prev
next
Full Article
Full Article
Figure & data
Reference
Citations
Metrics
Download PDF
Twitter
Facebook
Linked
Email
Abstract
No abstract available.
Figure & Data
References
Citations
Citations to this article as recorded by
Cite
CITE
export
Copy
Format
NLM
AMA
APA
MLA
Close
Download Citation
Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
Format:
RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
Include:
Citation for the content below
Citation and abstract for the content below
Significance of Anti-GAD Antibodies in Lean Patients with Type 2 Diabetes Mellitus.
Korean Diabetes J.
2004;28(2):63-65. Published online April 1, 2004
Close
Related articles
The Importance of Treating Hyperglycemia in β-Cell Dysfunction of Type 2 Diabetes Mellitus
Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
About this article
Park YS. Significance of Anti-GAD Antibodies in Lean Patients with Type 2 Diabetes Mellitus.. Diabetes Metab J. 2004;28(2):63-65.
DOI:
https://doi.org/
.
Download citation ↓
TOP